411MO Petosemtamab (MCLA-158) monotherapy in previously treated (2L+) recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase II trial

著者: C. Le Tourneau, J. Fayette, C. Even, Assuntina G. Sacco, Amaury Daste, Irene Braña, C. van Herpen, Thibault Mazard, S. Henry, Michael Saerens, Andrew K. Joe, Eduardo Pennella, Y-M. Shen, K. Bol, Lokesh Jain, Marta M. Ferrer, Richard de Leeuw, Antoine Hollebecque - Annals of Oncology 2024 被引用: 9